John Doyle, DrPH
President, Consulting, Fortrea
John Doyle, DrPH, leads a global team across the product development life cycle, helping customers navigate complex business and regulatory environments. With more than three decades of extensive industry knowledge including regulatory strategy, RWE, market access and HEOR, John has a track record of leading differentiated consulting organizations that drive innovation and growth and has previous experience at top-ten pharma and a top 5 CRO. Active in thought leadership, he has published more than 50 peer-reviewed papers and 100 conference abstracts. He has served on the faculty at the Columbia Mailman School of Public Health since 2005.
Talk to John about these topics and more:
- Tactics for driving health innovation
- Optimizing market access strategies for new therapies
- Demonstrating value through HEOR
- Drug development life cycle strategies
Ready to Connect?
Would you like to invite a life science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic: